Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2004 2
2006 1
2009 1
2012 1
2014 1
2016 1
2018 1
2021 3
2022 4
Text availability
Article attribute
Article type
Publication date

Search Results

17 results
Results by year
Filters applied: . Clear all
Page 1
Fc-Independent Protection from SARS-CoV-2 Infection by Recombinant Human Monoclonal Antibodies.
Noy-Porat T, Edri A, Alcalay R, Makdasi E, Gur D, Aftalion M, Evgy Y, Beth-Din A, Levy Y, Epstein E, Radinsky O, Zauberman A, Lazar S, Yitzhaki S, Marcus H, Porgador A, Rosenfeld R, Mazor O. Noy-Porat T, et al. Among authors: marcus h. Antibodies (Basel). 2021 Nov 8;10(4):45. doi: 10.3390/antib10040045. Antibodies (Basel). 2021. PMID: 34842604 Free PMC article.
Neutralization of SARS-CoV-2 Variants by rVSV-ΔG-Spike-Elicited Human Sera.
Yahalom-Ronen Y, Erez N, Fisher M, Tamir H, Politi B, Achdout H, Melamed S, Glinert I, Weiss S, Cohen-Gihon I, Israeli O, Izak M, Mandelboim M, Caraco Y, Madar-Balakirski N, Mechaly A, Shinar E, Zichel R, Cohen D, Beth-Din A, Zvi A, Marcus H, Israely T, Paran N. Yahalom-Ronen Y, et al. Among authors: marcus h. Vaccines (Basel). 2022 Feb 14;10(2):291. doi: 10.3390/vaccines10020291. Vaccines (Basel). 2022. PMID: 35214749 Free PMC article.
A Novel Quantitative Multi-Component Serological Assay for SARS-CoV-2 Vaccine Evaluation.
Fisher M, Manor A, Abramovitch H, Fatelevich E, Afrimov Y, Bilinsky G, Lupu E, Ben-Shmuel A, Glinert I, Madar-Balakirski N, Marcus H, Mechaly A. Fisher M, et al. Among authors: marcus h. Anal Chem. 2022 Mar 15;94(10):4380-4389. doi: 10.1021/acs.analchem.1c05264. Epub 2022 Mar 1. Anal Chem. 2022. PMID: 35230823 Free PMC article.
Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody.
Corti D, Misasi J, Mulangu S, Stanley DA, Kanekiyo M, Wollen S, Ploquin A, Doria-Rose NA, Staupe RP, Bailey M, Shi W, Choe M, Marcus H, Thompson EA, Cagigi A, Silacci C, Fernandez-Rodriguez B, Perez L, Sallusto F, Vanzetta F, Agatic G, Cameroni E, Kisalu N, Gordon I, Ledgerwood JE, Mascola JR, Graham BS, Muyembe-Tamfun JJ, Trefry JC, Lanzavecchia A, Sullivan NJ. Corti D, et al. Among authors: marcus h. Science. 2016 Mar 18;351(6279):1339-42. doi: 10.1126/science.aad5224. Epub 2016 Feb 25. Science. 2016. PMID: 26917593
Serologic Evidence of Ebolavirus Infection in a Population With No History of Outbreaks in the Democratic Republic of the Congo.
Mulangu S, Alfonso VH, Hoff NA, Doshi RH, Mulembakani P, Kisalu NK, Okitolonda-Wemakoy E, Kebela BI, Marcus H, Shiloach J, Phue JN, Wright LL, Muyembe-Tamfum JJ, Sullivan NJ, Rimoin AW. Mulangu S, et al. Among authors: marcus h. J Infect Dis. 2018 Jan 30;217(4):529-537. doi: 10.1093/infdis/jix619. J Infect Dis. 2018. PMID: 29329455 Free PMC article.
Preliminary nonclinical safety and immunogenicity of an rVSV-ΔG-SARS-CoV-2-S vaccine in mice, hamsters, rabbits and pigs.
Madar-Balakirski N, Rosner A, Melamed S, Politi B, Steiner M, Tamir H, Yahalom-Ronen Y, Bar-David E, Ben-Shmuel A, Sittner A, Glinert I, Weiss S, Bar-Haim E, Cohen H, Elia U, Achdout H, Erez N, Rotem S, Lazar S, Nyska A, Yitzhaki S, Beth-Din A, Levy H, Paran N, Israely T, Marcus H. Madar-Balakirski N, et al. Among authors: marcus h. Arch Toxicol. 2022 Mar;96(3):859-875. doi: 10.1007/s00204-021-03214-w. Epub 2022 Jan 15. Arch Toxicol. 2022. PMID: 35032184 Free PMC article.
17 results